iBio IncCommon Stock is a biotechnology business based in the US. iBio IncCommon Stock shares (IBIO) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $0.98 – a decrease of 7.06% over the previous week. iBio IncCommon Stock employs 16 staff and has a trailing 12-month revenue of around $375,000.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.98 |
|---|---|
| 52-week range | $0.64 - $6.89 |
| 50-day moving average | $3.33 |
| 200-day moving average | $2.68 |
| Wall St. target price | $4.80 |
| PE ratio | 0.7769 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $1.30 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.01 from 2025-05-02
| 1 week (2025-04-28) | -3.81% |
|---|---|
| 1 month (2025-04-04) | -68.68% |
| 3 months (2025-02-06) | -71.87% |
| 6 months (2024-11-06) | -60.70% |
| 1 year (2024-05-06) | -49.25% |
|---|---|
| 2 years (2023-05-05) | -95.37% |
| 3 years (2022-05-05) | 141.55 |
| 5 years (2020-05-06) | 535 |
Valuing iBio IncCommon Stock stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of iBio IncCommon Stock's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
iBio IncCommon Stock's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, iBio IncCommon Stock shares trade at around 1x recent earnings.
| Revenue TTM | $375,000 |
|---|---|
| Gross profit TTM | $375,000 |
| Return on assets TTM | -34.91% |
| Return on equity TTM | -123.28% |
| Profit margin | 0% |
| Book value | $1.52 |
| Market Capitalization | $10.2 million |
TTM: trailing 12 months
We're not expecting iBio IncCommon Stock to pay a dividend over the next 12 months.
iBio IncCommon Stock's shares were split on a 1:20 basis on 28 November 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your iBio IncCommon Stock shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for iBio IncCommon Stock shares which in turn could have impacted iBio IncCommon Stock's share price.
Over the last 12 months, iBio IncCommon Stock's shares have ranged in value from as little as $0.6358 up to $6.8908. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while iBio IncCommon Stock's is 1.022. This would suggest that iBio IncCommon Stock's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
iBio, Inc. , a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
See our picks for the best brokers for trading S&P 500 stocks, ETFs, options and futures.
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
These are the stocks to buy when you don’t have much to spend.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Thinking of switching from Moomoo? Here are 5 apps like Moomoo that offer valuable benefits
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Webull is a broker with zero-commission trading and a suite of tools to help you invest.